- Report
- April 2025
- 196 Pages
Global
From €5147EUR$5,450USD£4,378GBP
- Report
- February 2023
- 266 Pages
Global
From €3966EUR$4,200USD£3,374GBP
- Report
- October 2023
- 185 Pages
Global
From €4250EUR$4,500USD£3,615GBP
- Book
- May 2018
- 1064 Pages
- Book
- June 2009
- 608 Pages
- Book
- August 2019
North America
The HIV Prevention market within the context of Healthcare Services is focused on providing services to reduce the spread of HIV and AIDS. This includes providing education and awareness, testing and counseling, and access to antiretroviral therapy. Education and awareness programs are designed to inform individuals about the risks of HIV and how to protect themselves. Testing and counseling services are available to help individuals understand their HIV status and make informed decisions about their health. Access to antiretroviral therapy is also available to help individuals manage their HIV infection and reduce the risk of transmission.
Companies in the HIV Prevention market include Gilead Sciences, Merck, ViiV Healthcare, and GlaxoSmithKline. These companies provide a range of services, including research and development, manufacturing, and distribution of HIV prevention products. Additionally, they provide access to HIV prevention services, such as testing and counseling, and antiretroviral therapy. Show Less Read more
